CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $421,000 | -32.1% | 50,802 | -44.5% | 0.02% | -28.6% |
| Q4 2021 | $620,000 | +19.9% | 91,607 | -6.1% | 0.02% | +23.5% |
| Q3 2021 | $517,000 | +2.4% | 97,527 | +11.1% | 0.02% | 0.0% |
| Q2 2021 | $505,000 | +18.5% | 87,758 | -5.1% | 0.02% | +13.3% |
| Q1 2021 | $426,000 | +134.1% | 92,479 | +70.0% | 0.02% | +114.3% |
| Q4 2020 | $182,000 | +25.5% | 54,402 | +11.5% | 0.01% | +16.7% |
| Q3 2020 | $145,000 | -31.9% | 48,785 | +5.7% | 0.01% | -40.0% |
| Q2 2020 | $213,000 | +14.5% | 46,139 | -4.3% | 0.01% | +11.1% |
| Q1 2020 | $186,000 | – | 48,216 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |